ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : La Jolla Pharmaceutical Company

Include trials that are no longer recruiting patients.

2 studies were found.
1.CompletedSafety and Efficacy Study of LJP 394 (abetimus sodium) to treat lupus kidney disease
Conditions: Immunologic Diseases; Autoimmune Diseases; Systemic Lupus Erythematosus; Lupus Nephritis; Lupus Glomerulonephritis
2.RecruitingStudy of LJP 394 in Lupus Patients with History of Renal Disease
Conditions: Lupus Erythematosus, Systemic; Lupus Nephritis

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act